Literature DB >> 8654641

Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders.

S L Padilla1, K Dugan, V Maruschak, S Shalika, R D Smith.   

Abstract

OBJECTIVE: To analyze the effect of high dose human FSH in combination with hMG with a flare-up leuprolide acetate (LA) protocol in patients undergoing IVF at risk for a poor response.
DESIGN: Prospective.
SETTING: Free-standing ambulatory IVF center. PATIENTS: Two hundred eighty-four patients underwent a LA screening test for IVF. Patients with a lack of flare response were considered at risk for a poor response and underwent ovarian stimulation with the flare-up LA protocol in combination with high dose human FSH and hMG.
RESULTS: The poor responder group was compared with the good responders on the flare-up LA protocol and to patients undergoing ovulation induction with a luteal phase LA protocol. There were 53 poor responder flare-up LA cycles, 177 good responder flare-up LA cycles, and 54 luteal phase LA cycles. The cancellation rate was higher in poor flare-up LA responders (11.3 percent) compared with good flare-up LA responders (1.1 percent) and luteal phase LA cycles (1.8 percent). Peak E2 levels, number of oocytes, and number of embryos were significantly higher in the good flare-up LA responders. Fertilization rate was similar in all groups. Ongoing pregnancy rate per retrieval was 28 percent in good responders, 29 percent in poor responders, and 33 percent in luteal phase LA patients. Only one patient (0.4 percent) was hospitalized for severe ovarian hyperstimulation.
CONCLUSION: The flare-up protocol with high-dose human FSH and hMG is a very good alternative for patients who are at high risk for a poor response. Although peak E2 and number of oocytes were significantly lower in this group, the patients who responded had the same fertilization and pregnancy rate as the good responders. Cancellation rate remains high in poor responders.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8654641     DOI: 10.1016/s0015-0282(16)58216-8

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

1.  Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders.

Authors:  Pu-Tsui Wang; Robert Kuo-kuang Lee; Jin-Tsung Su; Jen-Wan Hou; Ming-Huei Lin; Yu-Ming Hu
Journal:  J Assist Reprod Genet       Date:  2002-01       Impact factor: 3.412

Review 2.  Management of the poor responder: the role of GnRH agonists and antagonists.

Authors:  Eric S Surrey
Journal:  J Assist Reprod Genet       Date:  2007-11-29       Impact factor: 3.412

3.  Meta-analysis of GnRH-antagonists versus GnRH-agonists in poor responder protocols.

Authors:  Myrto Papamentzelopoulou; Sofoklis Stavros; Despoina Mavrogianni; Christos Kalantzis; Dimitrios Loutradis; Petros Drakakis
Journal:  Arch Gynecol Obstet       Date:  2021-01-10       Impact factor: 2.344

4.  The appraisal of body content (ABC) trial: obesity does not significantly impact gamete production in infertile men and women.

Authors:  Julia Kim; Caroline Juneau; George Patounakis; Scott Morin; Shelby Neal; Emre Seli; Richard Scott
Journal:  J Assist Reprod Genet       Date:  2020-08-22       Impact factor: 3.412

Review 5.  Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet.

Authors:  S J Fasouliotis; A Simon; N Laufer
Journal:  J Assist Reprod Genet       Date:  2000-08       Impact factor: 3.412

6.  The need to step up the gonadotropin dosage in the stimulation phase of IVF treatment predicts a poor outcome.

Authors:  D L Hock; H Louie; R M Shelden; C V Ananth; E Kemmann
Journal:  J Assist Reprod Genet       Date:  1998-08       Impact factor: 3.412

Review 7.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

Review 8.  Contemporary pharmacological manipulation in assisted reproduction.

Authors:  Judith A F Huirne; Cornelis B Lambalk; Andre C D van Loenen; Roel Schats; Peter G A Hompes; Bart C J M Fauser; Nick S Macklon
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare -up protocol in poor responders: a preliminary study.

Authors:  Bülent Berker; Candan İltemir Duvan; Cemil Kaya; Ruşen Aytaç; Hakan Satıroğlu
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-12-01

10.  Oral contraceptive pretreatment does not improve outcome in microdose gonadotrophin-releasing hormone agonist protocol among poor responder intracytoplasmic sperm injection patients.

Authors:  Candan Iltemir Duvan; Bulent Berker; Nilgun Ozturk Turhan; Hakan Satiroglu
Journal:  J Assist Reprod Genet       Date:  2008-02-06       Impact factor: 3.412

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.